查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511838

藥物篩檢市場規模、佔有率、趨勢分析報告：按產品類型、樣本類型、最終用途、地區和細分市場預測，2024-2030 年

Drug Screening Market Size, Share & Trends Analysis Report By Product Type (Instruments, Rapid Testing Devices), By Sample Type (Urine Sample, Breath Sample), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

藥物篩檢市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球藥物篩檢市場規模預計將達到119.9億美元，預測期內複合年成長率為4.0%。

這個市場是由對準確檢測藥物濫用的需求推動的，而這種需求是由日益增加的職場安全問題、監管反應和測試方法的技術進步所驅動的。

英格蘭接觸毒品和酒精服務的成年人數量從2020-2021年的275,896人增加到2021-2022年的289,215人，增加了4.8%，這是該國毒品濫用現象的最大增幅。藥物濫用盛行率的上升進一步支持了有效預防和治療策略的必要性，包括擴大獲得循證治療方案的機會以及提高對藥物和酒精濫用風險的認知的公共衛生宣傳活動。

同樣，2020年美國12歲及以上非法藥物使用流行率約為3731萬人，較過去幾年與前一年同期比較成長3.8%，這種流行率的上升是市場的一個重要因素。這一增加凸顯了職場、學校和醫療機構迫切需要開展全面的藥物篩檢計劃，以確保安全、遵守法規，並為那些與藥物濫用作鬥爭的人們提供適當的護理和支持。

此外，新產品推出、合併和收購等市場參與者的舉措也促進了市場的成長。例如，2024 年 2 月，紐約領先的藥物檢測提供者 Mobile Health 為雇主推出了快速藥物檢測，一小時內即可得出結果。這項創新專注於高精度和多功能的尿液測試，推進了招募流程並徹底改變了紐約的人才招募。此外，FDA 將在 2023 年 12 月核准AvertD 測試，該測試透過基因標記評估個人罹患鴉片類藥物使用障礙的風險，這標誌著對抗鴉片類藥物危機的重大創新。該測試由 AutoGenomics 開發，旨在在患者首次接觸口服鴉片類止痛藥物之前使用，特別是計劃進行手術的患者。該測試旨在幫助患者和醫療保健提供者就鴉片類藥物的使用做出明智的決定，並降低成癮和濫用的風險。

AvertD 的核准是 FDA 解決鴉片類藥物危機的更廣泛努力的一部分，包括 2022 年 8 月推出 FDA過量攝取預防框架以及 2023 年 3 月和 7 月核准非處方納洛酮滴鼻劑。 FDA 對解決這場危機的承諾體現在我們對開發有助於評估和降低鴉片類藥物使用障礙風險的醫療設備的持續支持。

藥物篩檢市場報告亮點

  • 按產品類型分類，消耗品在 2023 年佔據了收益最快的市場佔有率，並且由於主要企業將採取廣泛的研發舉措，預計在預測期內將以最快的速度成長。
  • 按類型分類，尿液樣本佔據最大的收益佔有率，並在 2023 年佔據市場主導地位。尿液藥物檢測通常比其他檢測方法（例如毛髮檢測）更具成本效益。
  • 由於人們越來越關注藥物濫用治療和康復以及這些中心對藥物檢測服務的需求不斷增加，藥物治療中心的最終用途部分將在 2023 年佔據市場主導地位。
  • 由於先進的醫療基礎設施、非法藥物的高消費量以及職場藥物檢測的需求等因素，北美在全球市場中佔據主導地位。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章藥物篩檢市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • 藥物篩檢市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 價格分析

第4章藥物篩檢市場：產品類型估計與趨勢分析

  • 全球藥物篩檢市場：產品類型儀表板
  • 全球藥物篩檢市場：產品類型變化分析
  • 全球藥物篩檢市場：依產品類型、收益
  • 裝置
  • 快速檢測裝置
  • 消耗品
  • 服務及更多

第5章藥物篩檢市場：技術評估與趨勢分析

  • 全球藥物篩檢市場：樣品類型儀表板
  • 全球藥物篩檢市場：樣本類型變異分析
  • 全球藥物篩檢市場：依樣本類型、按收益
  • 尿液樣本
  • 呼吸樣本
  • 口腔液樣本
  • 頭髮樣本
  • 其他樣品

第6章藥物篩檢市場：最終用途估計與趨勢分析

  • 全球藥物篩檢市場：最終用途儀表板
  • 全球藥物篩檢市場：最終用途變異分析
  • 全球藥物篩檢市場：依最終用途、按收益
  • 醫院
  • 刑事司法和執法
  • 職場
  • 戒毒治療中心
  • 個人用戶
  • 疼痛管理中心
  • 學校和大學
  • 其他

第7章藥物篩檢市場：按產品類型、樣本類型和最終用途進行的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場占有率分析
    • Abbott
    • Quest Diagnostics Incorporated
    • F. Hoffmann-La Roche Ltd
    • Thermo Fisher Scientific Inc.
    • Siemens Healthcare AG
    • Laboratory Corporation of America Holdings
    • Alfa Scientific Designs, Inc.,
    • OraSure Technologies, Inc.
    • Omega Laboratories, Inc.
    • Dragerwerk AG &Co. KGaA
    • Bio-Rad Laboratories, Inc.
Product Code: GVR-4-68040-303-9

Drug Screening Market Growth & Trends:

The global drug screening market size is anticipated to reach USD 11.99 billion by 2030 and is growing at a CAGR of 4.0% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by increasing workplace safety concerns, regulatory compliance, and requirement for accurate detection of substance abuse, aided by technological advancements in testing methods.

The increase in number of adults in contact with drug and alcohol services in England has increased from 275,896 in 2020 - 2021¬ to 289,215 in 2021 - 2022, representing a 4.8% rise, which signifies a growing prevalence of substance abuse in the country. The rising prevalence of substance abuse further propels the need for effective prevention and treatment strategies, including the expansion of access to evidence-based treatment options and public health campaigns to raise awareness about the risks of drug and alcohol misuse.

Similarly, the incidence of illegal substance use among Americans aged 12 and older in 2020 was around 37.31 million, and shows a 3.8% year-over-year increase over the years; this rising prevalence serves as a significant driver for the market. This increase highlights the urgent need for comprehensive drug screening programs in workplaces, schools, and healthcare settings to ensure safety, compliance with regulations, and provision of appropriate care and support for individuals struggling with substance abuse.

Furthermore, initiatives by market players such as new product launches, mergers, acquisitions, and others contribute to market growth. For instance, in February 2024, Mobile Health, the leading drug testing provider in NYC, introduced rapid drug testing for employers, ensuring results in an hour or less. With a focus on urine-based testing for accuracy and versatility, this innovation advances the hiring process, revolutionizing talent acquisition in NYC. In addition, in December 2023, the FDA's approval of the AvertD test, which assesses an individual's risk of developing opioid use disorder through genetic markers, marks a significant innovation in the fight against the opioid crisis. This test, developed by AutoGenomics, Inc., is designed to be used before a patient is first exposed to oral opioid pain medications, particularly in patients scheduled for surgical procedures. The test is intended to help patients and healthcare providers make informed decisions about opioid use, potentially reducing the risk of addiction and misuse.

The approval of AvertD is part of FDA's broader efforts to address opioid crisis, which includes the introduction of FDA Overdose Prevention Framework in August 2022 and the approval of nonprescription naloxone nasal spray products in March and July 2023. The FDA's commitment to addressing these crisis is evident in its continued support for the development of medical devices that can help assess and mitigate the risk of opioid use disorder.

Drug Screening Market Report Highlights:

  • Consumables dominated the product type segment with the fastest revenue market share in 2023 and is anticipated to grow at fastest growth rate over the forecast period owing to extensive R&D initiatives undertaken by major players to develop kits
  • Based on type segment, urine sample dominated the market with the largest revenue share in 2023 attributed to the ease of collection. Urine drug testing is generally more cost-effective compared to other testing methods, such as hair testing
  • Drug treatment centers end-use segment dominated the market in 2023, attributed to the increasing focus on substance abuse treatment and rehabilitation, leading to a higher demand for drug testing services in these centers
  • North America dominated the global market owing to factors such as advanced healthcare infrastructure, the region's high consumption of illegal substances, and the necessity for workplace drug tests

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product Type
    • 1.2.2. Sample Type
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product type outlook
    • 2.2.2. Sample type outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Drug Screening Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing drug and alcohol consumption
      • 3.2.1.2. Growing demand for drug screening measures
      • 3.2.1.3. Rise in government funding
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Rising false positive and negative results in drug screeni9ng limits screening process
      • 3.2.2.2. Rise in privacy concerns limiting the expansion of drug screening practices
  • 3.3. Drug Screening Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Drug Screening Market: Product Type Estimates & Trend Analysis

  • 4.1. Global Drug Screening Market: Product Type Dashboard
  • 4.2. Global Drug Screening Market: Product Type Movement Analysis
  • 4.3. Global Drug Screening Market by Product Type, Revenue
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.2. Immunoassays Analyzers
      • 4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.3. Chromatography Instruments
      • 4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.4.4. Breath Analyzer
      • 4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.4.2. Fuel Cell Breath Analyzer
      • 4.4.4.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.4.3. Semi-conductor Breath Analyzer
      • 4.4.4.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.4.4.4. Others Breath Analyzer
      • 4.4.4.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.5. Rapid Testing Devices
    • 4.5.1. Rapid testing devices market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.2. Urine Testing Devices
      • 4.5.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.2. Drug Testing Cups
      • 4.5.2.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.3. Dip Cards
      • 4.5.2.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
      • 4.5.2.4. Drug Testing Cassettes
      • 4.5.2.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.3. Oral Fluid Testing Devices
      • 4.5.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.6. Consumables
    • 4.6.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.2. Assay Kits
      • 4.6.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.3. Sample Collection Devices
      • 4.6.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.4. Calibrators & Controls
      • 4.6.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.6.5. Other Consumables
      • 4.6.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
  • 4.7. Services and Others
    • 4.7.1. Services and others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Drug Screening Market: Technology Estimates & Trend Analysis

  • 5.1. Global Drug Screening Market: Sample Type Dashboard
  • 5.2. Global Drug Screening Market: Sample Type Movement Analysis
  • 5.3. Global Drug Screening Market by Sample Type, Revenue
  • 5.4. Urine Samples
    • 5.4.1. Urine samples market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.5. Breath Samples
    • 5.5.1. Breath samples market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.6. Oral Fluid Samples
    • 5.6.1. Oral fluid samples market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.7. Hair Samples
    • 5.7.1. Hair samples market estimates and forecasts 2018 - 2030 (USD Million)
  • 5.8. Other Samples
    • 5.8.1. Other samples market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Drug Screening Market: End-use Estimates & Trend Analysis

  • 6.1. Global Drug Screening Market: End-use Dashboard
  • 6.2. Global Drug Screening Market: End-use Movement Analysis
  • 6.3. Global Drug Screening Market by End-use, Revenue
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.5. Criminal Justice & Law Enforcement Agencies
    • 6.5.1. Clinical laboratories market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.6. Workplaces
    • 6.6.1. Workplaces market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.7. Drug Treatment Centers
    • 6.7.1. Drug treatment centers market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.8. Individual Users
    • 6.8.1. Individual users market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.9. Pain Management Centers
    • 6.9.1. Pain management centers market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.10. Schools & Colleges
    • 6.10.1. Schools & Colleges market estimates and forecasts 2018 - 2030 (USD Million)
  • 6.11. Others
    • 6.11.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Drug Screening Market: Regional Estimates & Trend Analysis by Product Type, Sample Type, and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Abbott
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Quest Diagnostics Incorporated
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. F. Hoffmann-La Roche Ltd
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Thermo Fisher Scientific Inc.
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Siemens Healthcare AG
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Laboratory Corporation of America Holdings
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Alfa Scientific Designs, Inc.,
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. OraSure Technologies, Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Omega Laboratories, Inc.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Dragerwerk AG & Co. KGaA
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Bio-Rad Laboratories, Inc.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America drug screening market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 4 North America drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 5 North America drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 7 U.S. drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 8 U.S. drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 10 Canada drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 11 Canada drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Mexico drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 13 Mexico drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 14 Mexico drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe drug screening market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 17 Europe drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 18 Europe drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 20 UK drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 21 UK drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Germany drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 23 Germany drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 24 Germany drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 France drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 26 France drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 27 France drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Italy drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 29 Italy drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 30 Italy drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Spain drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 32 Spain drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 33 Spain drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Denmark drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 35 Denmark drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 36 Denmark drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Sweden drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 38 Sweden drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 39 Sweden drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Norway drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 41 Norway drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 42 Norway drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific drug screening market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 46 Aisa Pacific drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 48 Japan drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 49 Japan drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 China drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 51 China drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 52 China drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 India drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 54 India drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 55 India drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Australia drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 57 Australia drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 58 Australia drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Korea drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 60 South Korea drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 61 South Korea drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Thailand drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 63 Thailand drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 64 Thailand drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America drug screening market, by region, 2018 - 2030 (USD Million)
  • Table 66 Latin America drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 67 Latin America drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 68 Latin America drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Brazil drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 70 Brazil drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 71 Brazil drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 73 Argentina drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 74 Argentina drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 MEA drug screening market, by region, 2018 - 2030 (USD Million)
  • Table 76 MEA drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 77 MEA drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 78 MEA drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 South Africa drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 80 South Africa drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 81 South Africa drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 86 UAE drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 87 UAE drug screening market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait drug screening market, by product type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait drug screening market, by sample type, 2018 - 2030 (USD Million)
  • Table 90 Kuwait drug screening market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Drug screening market: market outlook
  • Fig. 14 Drug screening competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Drug screening market driver impact
  • Fig. 18 Drug screening market restraint impact
  • Fig. 19 Drug screening market: Product type movement analysis
  • Fig. 20 Drug screening market: Product type outlook and key takeaways
  • Fig. 21 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Immunoassays analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Chromatography instruments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Fuel cell breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Semi-conductor breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Others breath analyzers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Rapid testing devices estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Urine testing devices estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Drug testing cups estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Dip cards estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Drug testing cassettes estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Oral fluid testing devices estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Consumables estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Assay kits estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Sample collection devices estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Calibrators & controls estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Other consumables estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Services and others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Drug screening market: Sample type movement analysis
  • Fig. 41 Drug screening market: Sample type outlook and key takeaways
  • Fig. 42 Urine samples market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Breath samples estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Oral fluid samples market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Hair samples estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Other samples estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Drug screening market: End-use movement analysis
  • Fig. 48 Drug screening market: End-use outlook and key takeaways
  • Fig. 49 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Criminal justice and law enforcement agencies estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Workplaces market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Drug treatment centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Individual users market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Pain management centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Schools & colleges market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Global drug screening market: Regional movement analysis
  • Fig. 58 Global drug screening market: Regional outlook and key takeaways
  • Fig. 59 Global drug screening market share and leading players
  • Fig. 60 North America, by country
  • Fig. 61 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 U.S. key country dynamics
  • Fig. 63 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Canada key country dynamics
  • Fig. 65 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Mexico key country dynamics
  • Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UK key country dynamics
  • Fig. 70 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Germany key country dynamics
  • Fig. 72 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 France key country dynamics
  • Fig. 74 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Italy key country dynamics
  • Fig. 76 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Spain key country dynamics
  • Fig. 78 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Denmark key country dynamics
  • Fig. 80 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Sweden key country dynamics
  • Fig. 82 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Norway key country dynamics
  • Fig. 84 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Japan key country dynamics
  • Fig. 87 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 China key country dynamics
  • Fig. 89 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 India key country dynamics
  • Fig. 91 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Australia key country dynamics
  • Fig. 93 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 South Korea key country dynamics
  • Fig. 95 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Thailand key country dynamics
  • Fig. 97 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Brazil key country dynamics
  • Fig. 100 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Argentina key country dynamics
  • Fig. 102 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 South Africa key country dynamics
  • Fig. 105 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Saudi Arabia key country dynamics
  • Fig. 107 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 UAE key country dynamics
  • Fig. 109 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Kuwait key country dynamics
  • Fig. 111 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 112 Market share of key market players- Global drug screening market